Pharmaceutical Executive
The 2017 GPS ranking evaluates clinical trial registration, results reporting, clinical study report synopsis sharing, and journal article publication rates for new drugs approved by the Food and Drug Administration in 2014 that were sponsored by large drug companies.
Pharmaceutical Executive
Click the title above to open the Pharmaceutical Executive December 2017 issue in an interactive PDF format.
Pharmaceutical Executive
Pharmaceutical Executive
John Sattler offers some tips on engaging executive and professional recruiters.
Pharmaceutical Executive
Agency leaders go slow in weighing changes to DTC ads and off-label marketing. Jill Wechsler reports.
Pharmaceutical Executive
Our annual look at the drug industry's pipeline-the progress and the setbacks-puts my thoughts on those people driving new science behind the scenes in pharmaceutical research.
Pharmaceutical Executive
A deep dive into the outlook and implications from the UK’s recently unveiled life sciences blueprint for a post-Brexit world.
Pharmaceutical Executive
Outlining the common data transactions between life sciences companies and the HIPAA-regulated stakeholders they deal with daily-and steps pharma can take to secure and protect its own data.
Pharmaceutical Executive
Click the title above to open the Pharmaceutical Executive November 2017 issue in an interactive PDF format.
Pharmaceutical Executive
Navigating Data Privacy and Security Considerations in the Life Sciences Industry
Pharmaceutical Executive
Brenda Gleason discusses the current health policy landscape and how future pharmacists can be healthcare leaders during a lecture at University of North Carolina Eshelman School of Pharmacy.
Pharmaceutical Executive
Pharmaceutical Executive
Pharmaceutical Executive
Pharmaceutical Executive
Pharmaceutical Executive
Pharmaceutical Executive